Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
112.50    0.00 (0.00%)
Bid:
110.00
Ask:
115.00
Spread: 5.00 (4.545%)
Market Cap: £67.68m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update & Contract Win

5 Apr 2022 07:00

RNS Number : 2229H
Intercede Group PLC
05 April 2022
 

 

 

 

5 April 2022

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

Trading Update & Contract Win

 

Intercede, the leading specialist in digital identity, credential management and secure mobility, announces that, subject to the completion of the year end audit, revenues for the year ended 31 March 2022 are expected to be in the region of £9.9-10.0m, which is approximately 9% lower than the previous financial year (4% lower at constant exchange rates).

 

Whilst the number of new deployments is the highest in recent years, delays have been experienced with a number of large new opportunities that had been expected to close this year and consequently there has not been a substantial license order received during the year ended 31 March 2022. Furthermore, COVID-19 has continued to impact trading outside the US market.

 

Although revenues are lower than market expectations, strong progress has been made during the past year with all other aspects of the business. MyID v12 has been launched which includes FIDO functionality thereby enabling the Group to substantially increase its addressable market following the long-awaited issue of FIPS 201-3 which finally took place in February 2022. New partnerships have also been formed during the year in Europe, the US, ASEAN, Latin America and Africa which is critical for the Group's future growth prospects.

 

Having increased the value of annual recurring revenues from Support & Maintenance plus repeatable Professional Services revenues to reach the point where they now largely cover annual fixed costs, the Group is expected to remain profitable. As at 31 March 2022, gross cash balances totalled £7.8m (2021: £8.0m).

 

Further detail will be provided within Intercede's final results which are expected to be published in June 2022.

 

Contract Win

 

Further to the announcement of 2 February 2022, Intercede announces that it received an initial order totalling $0.3m immediately prior to the year end from another large and prestigious US Federal Agency, a portion of which will be recognised in the year ended 31 March 2022.

 

The contract relates to the supply of Intercede's MyID credential management software to deploy digital identities to mobile devices in the form of derived PIV credentials, compliant with US government security standards FIPS 201 and SP 800-157. Intercede will work closely with its new partner to commence the migration from a competitor.

 

 

ENQUIRIES

 

Intercede Group plc  Tel. +44 (0)1455 558 111Klaas van der Leest, Chief Executive

Andrew Walker, Finance Director

 

finnCap Tel. +44 (0)20 7220 0500Simon Hicks / Fergus Sullivan, Corporate Finance

Tim Redfern / Charlotte Sutcliffe, ECM

 

 

 

About Intercede

 

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

 

For more information visit: www.intercede.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUCUCUPPGMC
Date   Source Headline
1st Dec 20147:00 amRNSTransaction in Own Shares
10th Nov 20149:28 amRNSDirector and PDMR Share Option Awards
6th Nov 20147:00 amRNSShare Buyback Programme
6th Nov 20147:00 amRNSHalf Yearly Report
7th Oct 20147:00 amRNSTrading Update
29th Sep 20147:00 amRNSFirst Customer: Derived Credentials for Mobile
17th Sep 20144:25 pmRNSResult of AGM
1st Aug 20147:00 amRNSShare Incentive Plan
26th Jun 20149:37 amRNSDirector/PDMR Shareholding
25th Jun 20141:20 pmRNSDirector Share Dealings
10th Jun 20147:00 amRNSDirector Share Dealings
5th Jun 20147:00 amRNSFinal Results
6th May 201410:32 amRNSShare Incentive Plan
1st Apr 20147:00 amRNSDirectorate Change
27th Mar 20147:00 amRNSTransaction in Own Shares
25th Mar 201410:35 amRNSTransfer of Treasury Shares
20th Mar 20147:00 amRNSTransaction in Own Shares
13th Mar 20147:00 amRNSShare Incentive Plan
13th Mar 20147:00 amRNSTransfer of Treasury Shares
4th Mar 20149:09 amRNSTransaction in Own Shares
27th Feb 20147:00 amRNSTransaction in Own Shares
13th Feb 20147:00 amRNSTransaction in Own Shares
7th Feb 20147:00 amRNSPartnership with TELUS and Gemalto
5th Feb 20147:00 amRNSTransaction in Own Shares
28th Jan 201411:30 amRNSTransaction in Own Shares
13th Jan 20147:00 amRNSShare Buyback Programme
8th Jan 20147:00 amRNSTrading Update
10th Dec 20136:00 pmRNSDirector Share Dealings
10th Dec 20134:49 pmRNSDirector Share Dealings
21st Nov 20137:00 amRNSHalf Yearly Report
5th Nov 20137:00 amRNSNew Contract Win
1st Oct 20137:00 amRNSDirector Share Dealings
26th Sep 20137:00 amRNSDirector/PDMR Shareholding
25th Sep 20131:00 pmRNSResult of AGM
25th Sep 20137:00 amRNSContract Wins and AGM Statement
9th Sep 20137:00 amRNSDirectors' Holding
29th Jul 20137:00 amRNSContract awards and Trading update
17th Jun 20137:00 amRNSDirector/PDMR Shareholding
4th Jun 20137:00 amRNSFinal Results
25th Apr 20137:00 amRNSContract Win
16th Apr 20137:00 amRNSAppointment of Non-Executive Director
5th Apr 20137:00 amRNSYear end trading update
1st Feb 20137:00 amRNSTrading Update
3rd Dec 20127:00 amRNSHolding(s) in Company
22nd Nov 20127:00 amRNSInterim Results
4th Oct 20127:00 amRNSTrading Update
26th Sep 20124:39 pmRNSResult of AGM
21st Aug 20127:00 amRNSAmendments to LTIP
4th Jul 20123:35 pmRNSDirector/PDMR Shareholding
14th Jun 20122:37 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.